 TORONTO, Aug. 16, 2021 GLOBE NEWSWIRE -- Field Trip Health Ltd. TSX: FTRP; FTRP.WT; Nasdaq: FTRP Field Trip, a leader in the development and delivery of psychedelic therapies, reported its fiscal first quarter 2022 results for the three months ended June 30, 2021. All results are reported under International Financial Reporting Standards IFRS and in Canadian dollars, unless otherwise specified. 